|
1
|
Furrer MA, Costello DM, Thomas BC, Peters JS, Costello AJ, Dundee P. Robotics in Australian urology contemporary practice and future perspectives. ANZ J Surg 2021; 91:2241-2245. [PMID: 34766679 DOI: 10.1111/ans.17161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2021] [Revised: 06/27/2021] [Accepted: 08/10/2021] [Indexed: 11/30/2022]
Affiliation(s)
- Marc A Furrer
- Department of Urology, The University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.,The Australian Medical Robotics Academy, Melbourne, Victoria, Australia.,Epworth Healthcare, Melbourne, Victoria, Australia.,Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia.,Department of Urology, University Hospital of Bern, University of Bern, Bern, Switzerland
| | - Daniel M Costello
- The Australian Medical Robotics Academy, Melbourne, Victoria, Australia.,Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia
| | - Benjamin C Thomas
- Department of Urology, The University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.,The Australian Medical Robotics Academy, Melbourne, Victoria, Australia.,Epworth Healthcare, Melbourne, Victoria, Australia.,Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia.,Australian Prostate Cancer Centre, North Melbourne, Victoria, Australia
| | - Justin S Peters
- Department of Urology, The University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.,The Australian Medical Robotics Academy, Melbourne, Victoria, Australia.,Epworth Healthcare, Melbourne, Victoria, Australia.,Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia.,Australian Prostate Cancer Centre, North Melbourne, Victoria, Australia
| | - Anthony J Costello
- Department of Urology, The University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.,The Australian Medical Robotics Academy, Melbourne, Victoria, Australia.,Epworth Healthcare, Melbourne, Victoria, Australia.,Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia.,Australian Prostate Cancer Centre, North Melbourne, Victoria, Australia
| | - Philip Dundee
- Department of Urology, The University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.,The Australian Medical Robotics Academy, Melbourne, Victoria, Australia.,Epworth Healthcare, Melbourne, Victoria, Australia.,Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia.,Australian Prostate Cancer Centre, North Melbourne, Victoria, Australia
| |
Collapse
|
|
2
|
Rinott Mizrahi G, Freifeld Y, Klein I, Boyarsky L, Zreik R, Orlin I, Friedman B, Stein A, Yoram D. Comparison of Partial and Radical Laparascopic Nephrectomy: Perioperative and Oncologic Outcomes for Clinical T2 Renal Cell Carcinoma. J Endourol 2018; 32:950-954. [DOI: 10.1089/end.2018.0199] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
Affiliation(s)
| | - Yuval Freifeld
- Department of Urology, Carmel Medical Center, Haifa, Israel
| | - Ilan Klein
- Department of Urology, Carmel Medical Center, Haifa, Israel
| | | | - Rani Zreik
- Department of Urology, Carmel Medical Center, Haifa, Israel
| | - Ido Orlin
- Department of Urology, Carmel Medical Center, Haifa, Israel
| | - Boris Friedman
- Department of Urology, Carmel Medical Center, Haifa, Israel
| | - Avi Stein
- Department of Urology, Carmel Medical Center, Haifa, Israel
- Ruth and Bruce Rappaport School of Medicine, Technion, Haifa, Israel
| | - Dekel Yoram
- Department of Urology, Carmel Medical Center, Haifa, Israel
| |
Collapse
|
|
3
|
Aben KKH, Osanto S, Hulsbergen-van de Kaa CA, Soetekouw PM, Stemkens D, Bex A. Adherence to guideline recommendations for management of clinical T1 renal cancers in the Netherlands: a population-based study. World J Urol 2016; 34:1053-60. [PMID: 27178711 PMCID: PMC4958124 DOI: 10.1007/s00345-016-1841-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2015] [Accepted: 04/27/2016] [Indexed: 10/30/2022] Open
Abstract
PURPOSE For decades, small renal cancers are treated by radical nephrectomy (RN). Current guidelines recommend partial nephrectomy (PN) to preserve renal function and minimize cardiovascular comorbidity. As adherence to guidelines is largely unknown and international comparison to evaluate quality of health care is lacking, an pre-specified guideline evaluation of quality indicators concerning management of cT1 renal cancers was performed. METHODS We performed a cohort study including patients with cT1 renal cancer between 2010 and 2014, identified through the Netherlands Cancer Registry. Time trends and variation in treatment were described. Factors associated with PN in cT1a and laparoscopic RN in cT1b were evaluated with logistic regression analyses. RESULTS An increase in nephron-sparing treatment strategies (NSS) of cT1a patients (N total = 2436) was observed; in 2014, 67 % underwent NSS (62 % PN and 5 % thermal ablation). Age, a non-central tumor localization and being treated in a high-volume hospital were associated with PN. Although NSS were applied more frequently over time, the majority (70 %) of cT1b patients (N total = 2205) underwent RN in 2014, mainly performed laparoscopically. Increasing tumor size, tumor localization in the right kidney and being treated in a university hospital were associated with a lower probability of a laparoscopic RN versus open. Treatment in a high-volume hospital was associated with a higher probability of laparoscopic RN. CONCLUSIONS Dutch patients with cT1 renal cancer are predominantly treated according to current guidelines. Data of this pre-specified quality indicator analysis of a urological national guideline may serve as a model for international comparison of treatment of cT1 renal cancers.
Collapse
Affiliation(s)
- Katja K H Aben
- Netherlands Comprehensive Cancer Organisation, P.O. Box 19079, 3501 DB, Utrecht, The Netherlands. .,Radboud Institute for Health Sciences, Radboud University Medical Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. .,Netherlands Comprehensive Cancer Organisation, P.O. Box 1281, 6501 BG, Nijmegen, The Netherlands.
| | - Susanne Osanto
- Department of Oncology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC, Leiden, The Netherlands
| | | | - Patricia M Soetekouw
- Department of Oncology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands
| | - Daphne Stemkens
- Netherlands Comprehensive Cancer Organisation, P.O. Box 19079, 3501 DB, Utrecht, The Netherlands
| | - Axel Bex
- Department of Urology, Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands
| |
Collapse
|